Conferences
22 March 2022, Online
Webinar on Clinical Medicine | New Developments about Portal Vein Thrombosis in Cirrhosis
Portal vein thrombosis (PVT) frequently affects patients with cirrhosis. However, while in the absence of cirrhosis PVT frequently relies on underlying pro-thrombotic factors (and consequently the need of anticoagulation is obvious), in the context of cirrhosis PVT is considered to be secondary to liver disease, and whether PVT is a cause or a consequence of impaired liver function is controversial.
In contrast with the formal suggestion to treat with anticoagulants PVT in the context of cirrhosis, the issue of the management of PVT remains controversial. Actually, in clinical practice, the decision in most of the cases is not to treat due to the fear for an increased bleeding risk. Additionally, accumulating evidence suggests that spontaneous recanalization of PVT may occur without treatment.
This webinar has the aim of exploring open issues regarding PVT in cirrhosis, in particular about pathophysiology, outcome and management.
The following experts will be present and talk:
- Dr. Andrea Mancuso, Medicina Interna 1, Azienda di Rilievo Nazionale ad Alta Specializzazione Civico - Di Cristina - Benfratelli, Palermo, Italy
- Dr. Xingshun Qi, General Hospital of Northern Theater Command, Department of Gastroenterology, Shenyang, China
- Dr. Ton Lisman, Surgical Research Laboratory and Section of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, University Medical Center Groningen, Groningen, the Netherlands
- Dr. Aurelie Plessier, Coordination of national referral centre for vascular disorders of the liver (CRMVF). Full time Hepatology and portal hypertension unit consultant, Hopital Beaujon, Clichy, France
When? 22 March 2022 at 3:00pm CET | 9:00am EST | 10:00pm CST Asia
Register now for free!
